LA FILOLOGIA CLASSICA.MER,BARBEL.

Por KRAMER,JOHANNES. E KRAMER,BARBEL.
Publicado em C197

Die Lehnwörter im Wortschatz der spätbyzantinischen historiographischen Literatur

Por Zervan, Vratislav, Kramer, Johannes, Römer, Claudia, Metzeltin, Michael, Pavlovic, Bojana, Cuomo, Andrea Massimo
Publicado em 2018-12

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease

Por Wagner, Martin, Krämer, Johannes, Blohm, Elisabeth, Vergho, Dorothee, Weidemann, Frank, Breunig, Frank, Wanner, Christoph
Publicado no BMC Nephrol (2014)

Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry Cardiomyopathy

Por Krämer, Johannes, Nordbeck, Peter, Störk, Stefan, Ritter, Christian, Ertl, Georg, Wanner, Christoph, Weidemann, Frank
Publicado no JIMD Rep (2015)

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy

Por Krämer, Johannes, Bijnens, Bart, Störk, Stefan, Ritter, Christian O., Liu, Dan, Ertl, Georg, Wanner, Christoph, Weidemann, Frank
Publicado no PLoS One (2015)

Chiral modes and directional lasing at exceptional points

Por Peng, Bo, Özdemir, Şahin Kaya, Liertzer, Matthias, Chen, Weijian, Kramer, Johannes, Yılmaz, Huzeyfe, Wiersig, Jan, Rotter, Stefan, Yang, Lan
Publicado no Proc Natl Acad Sci U S A (2016)

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

Por Seydelmann, Nora, Liu, Dan, Krämer, Johannes, Drechsler, Christiane, Hu, Kai, Nordbeck, Peter, Schneider, Andreas, Störk, Stefan, Bijnens, Bart, Ertl, Georg, Wanner, Christoph, Weidemann, Frank
Publicado no J Am Heart Assoc (2016)

Potential role of vitamin D deficiency on Fabry cardiomyopathy

Por Drechsler, Christiane, Schmiedeke, Benjamin, Niemann, Markus, Schmiedeke, Daniel, Krämer, Johannes, Turkin, Irina, Blouin, Katja, Emmert, Andrea, Pilz, Stefan, Obermayer-Pietsch, Barbara, Weidemann, Frank, Breunig, Frank, Wanner, Christoph
Publicado em 2013

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant

Por Lenders, Malte, Weidemann, Frank, Kurschat, Christine, Canaan-Kühl, Sima, Duning, Thomas, Stypmann, Jörg, Schmitz, Boris, Reiermann, Stefanie, Krämer, Johannes, Blaschke, Daniela, Wanner, Christoph, Brand, Stefan-Martin, Brand, Eva
Publicado no Orphanet J Rare Dis (2016)

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch–2-Year Follow-Up

Por Lenders, Malte, Canaan-Kühl, Sima, Krämer, Johannes, Duning, Thomas, Reiermann, Stefanie, Sommer, Claudia, Stypmann, Jörg, Blaschke, Daniela, Üçeyler, Nurcan, Hense, Hans-Werner, Brand, Stefan-Martin, Wanner, Christoph, Weidemann, Frank, Brand, Eva
Publicado no J Am Soc Nephrol (2016)

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch

Por Weidemann, Frank, Krämer, Johannes, Duning, Thomas, Lenders, Malte, Canaan-Kühl, Sima, Krebs, Alice, González, Hans Guerrero, Sommer, Claudia, Üçeyler, Nurcan, Niemann, Markus, Störk, Stefan, Schelleckes, Michael, Reiermann, Stefanie, Stypmann, Jörg, Brand, Stefan-Martin, Wanner, Christoph, Brand, Eva
Publicado em 2014

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease

Por Lenders, Malte, Hennermann, Julia B., Kurschat, Christine, Rolfs, Arndt, Canaan-Kühl, Sima, Sommer, Claudia, Üçeyler, Nurcan, Kampmann, Christoph, Karabul, Nesrin, Giese, Anne-Katrin, Duning, Thomas, Stypmann, Jörg, Krämer, Johannes, Weidemann, Frank, Brand, Stefan-Martin, Wanner, Christoph, Brand, Eva
Publicado no Orphanet J Rare Dis (2016)